...
首页> 外文期刊>Cardiology Journal >Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants
【24h】

Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants

机译:新生儿和婴儿耐药性室上性心动过速的导管消融

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The aim of this study was to evaluate the indications, results and complicationsof radiofrequency ablation (RFA) and transcatheter cryoablation (TCA) in neonates andinfants with incessant drug-resistant supraventricular tachycardia (SVT).Methods: Out of 225 patients who underwent RFA and TCA at our center between January2010 and February 2012, 5 patients under the age of 1 (4 male, 1 female) were evaluated. Theindication for RFA/TCA was recurrent hemodynamically compromising drug-resistant SVT.Results: Over a 2-year period, 6 ablation procedures were performed in 5 patients. Averagepatient age was 3.3 ± 3.9 months (12 days – 9.5 months); average patient weight was 5.4 ± 2.2 kg (3.5–9 kg). One patient had ventricular septal defect, 1 had corrected transposition of great arteries, ventricular septal defect, right ventricular hypoplasia and pulmonary hypertension, while 3 had only patent foramen ovale. Electrophysiology study showed 1 accessory pathway in each patient (right posteroseptal in 2, left posteroseptal in 2 and left lateral in 1). The pathway was manifest in 1 patient with Wolff-Parkinson-White syndrome (WPW) andconcealed in the rest. Two of the concealed pathways had slow conduction time and decremental properties (the permanent form of junctional reciprocating tachycardia). Two patients underwentTCA and 3 — RFA, with an acute success rate of 100%. In the first week after the procedure, the patient with the complex cardiac anomaly and WPW developed recurrence and under went ablation again. Four of the procedures were carried out using an electroanatomic mapping system besides fluoroscopy. Average procedure time was 167 min (100–234); fluoroscopy time was 8.2 min (0.7–19.7). None of the patients developed major complications. After the average follow-upperiod of 6.5 months (3–18), all patients were symptom-free without medication.Conclusions: RFA and TCA can be performed successfully in neonates and infants within cessant medically refractory SVT.
机译:背景:本研究旨在评估持续耐药的室上性心动过速(SVT)持续性新生儿和婴儿的射频消融(RFA)和经导管冷冻消融(TCA)的适应症,结果和并发症。在2010年1月至2012年2月间,我们对5名1岁以下的患者(男性4例,女性1例)进行了评估。 RFA / TCA的指征是复发性血液动力学损害耐药性SVT。结果:在2年的时间里,对5例患者进行了6次消融。平均患者年龄为3.3±3.9个月(12天– 9.5个月);患者平均体重为5.4±2.2千克(3.5–9千克)。 1例有室间隔缺损,1例已纠正大动脉移位,室间隔缺损,右室发育不全和肺动脉高压,3例仅卵圆孔未闭。电生理学研究显示每位患者有1条辅助途径(右后隔2个,左后隔2个和左侧1个)。该通路在1例Wolff-Parkinson-White综合征(WPW)的患者中很明显,而在其余患者中则隐匿。两种隐蔽途径具有较慢的传导时间和递减特性(结节性往复性心动过速的永久形式)。两名患者接受了TCA和3-RFA治疗,急性成功率为100%。在手术后的第一周,患有复杂心脏异常和WPW的患者复发并再次消融。除荧光检查外,还使用电解剖标测系统执行了其中四个程序。平均手术时间为167分钟(100–234);透视时间为8.2分钟(0.7-19.7)。没有患者发生重大并发症。在平均随访6.5个月(3-18)后,所有患者均无症状,无需药物治疗。结论:RFA和TCA可以在药物治疗难治性SVT内的新生儿和婴儿中成功进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号